In clinical study planning, the relationship between sponsors and Contract Research Organizations (CROs) is crucial. As a Head of Clinical Operations, you understand how these partnerships help bring treatments to patients. However, aligning enrollment forecasts, study planning, and risk reduction strategies can be challenging.

Digital world map with data visualization icons.

The Challenge: Addressing the Data Gap and Reducing Risks

We know how it feels to be overworked, spending weeks compiling data from ClinicalTrials.gov and PubMed, dealing with CROs’ differing timelines, and lacking the critical data you need – all while trying to keep your studies on track.

Many clinical operations leaders share common concerns:

  • Differences between their enrollment estimates and those from CROs
  • Limited access to current site enrollment data
  • The need for effective risk reduction strategies in an unpredictable global environment

These challenges can result in:

  • Uncertainty when making decisions
  • Possible delays in study timelines
  • Difficulties allocating resources
  • Increased vulnerability to regulatory changes or unexpected events in specific regions

These issues often stem from a lack of a shared, data-driven foundation for discussions and planning. Without comprehensive, current data, sponsors and CROs may work from different assumptions, leading to mismatched expectations and increased study risks. The frustration of spending weeks manually compiling data could be avoided with a platform like Seer Crystal™.

The Solution: Giving Sponsors Comprehensive Data-Driven Answers

Seer Crystal™ is a predictive analytics tool designed to provide clinical operations teams with actionable, data-driven insights, eliminating the need for manually compiling data from multiple sources like ClinicalTrials.gov and PubMed, thus saving significant time and effort. Using Seer Crystal™, you can:

  • Create reliable enrollment forecasts: Use historical data and predictive models to develop realistic enrollment estimates.
  • Find potential study locations: Identify sites likely to enroll successfully based on past performance and relevant factors.
  • Compare various scenarios: Explore different study design options and their potential impact on enrollment and timelines.
  • Assess multi-regional strategies: Evaluate the likelihood and benefits of running studies across multiple markets or countries.
  • Improve risk reduction: Develop strategies to distribute study risk across different regions, ensuring continuity even if challenges arise in one area.
Person analyzing clinical trial data on computer screen.

Enhancing Collaboration and Risk Management

With these insights, you can approach CRO bid defenses and ongoing collaborations confidently, challenging CRO assumptions with evidence-backed data, leading to more balanced power dynamics during discussions. Here’s how Seer Crystal™ can enhance your partnerships and risk management:

  • Evidence-based discussions: Present data-supported estimates and scenarios during bid defenses, enabling more focused and productive conversations.
  • Shared understanding: Use Seer Crystal™’s visualizations to clearly communicate your expectations and reasoning behind study design decisions.
  • Ongoing alignment: Regularly compare actual enrollment data against Seer Crystal™’s predictions to identify and address any differences early in the study process.
  • Strategic site selection: Use insights to diversify site locations, balancing enrollment potential with risk reduction.
  • Regulatory preparedness: Plan for potential regulatory challenges by evaluating multiple regional options.

Addressing the Data Access Challenge

While CROs and site networks often protect their enrollment data, Seer Crystal™ offers a valuable alternative. By combining and analyzing a wide range of historical and current data sources, our tool offers a comprehensive view of enrollment trends and site performance. This comprehensive view reduces the dependency on CROs’ often-proprietary data, making it easier to push back on unrealistic proposals. This allows you to:

  • Make data-driven decisions without relying solely on CRO-provided information
  • Compare CRO proposals against independent data analysis
  • Identify potential differences or areas for further investigation

A Beneficial Approach for All

By bringing comprehensive, data-driven insights to the table, you’re not just improving your own planning process – you’re also providing valuable information to your CRO partners. This approach can lead to:

  • More accurate study proposals from CROs
  • Better resource allocation for both sponsors and CROs
  • Fewer timeline delays and budget overruns
  • A foundation for trust and transparency in the sponsor-CRO relationship
  • Improved ability to meet study diversity requirements through strategic site selection
Doctors analyzing medical data on screens.

The Future of Clinical Study Planning

As clinical research continues to change, the ability to make data-driven decisions and effectively reduce risks will become increasingly important. By using tools like Seer Crystal™ in your planning process, you’re not just improving your current studies – you’re preparing your organization for the future of clinical research.

Seer Crystal™ offers a user-centered approach to clinical study planning, giving you the foresight needed to make confident decisions. By bringing these insights to your CRO partnerships, you’re fostering a more collaborative, transparent, and efficient clinical study ecosystem.

Ready to see how Seer Crystal™ can bring clarity to your clinical operations? Contact us today to learn how our tool can save you time, help you plan studies, enhance your partnerships with CROs, and develop robust risk reduction strategies.

Related